Adriamycin-induced delayed erythropoietic injury expressed following anemia stress

Paul G Braunschweiger, L. L. Schenken, L. M. Schiffer

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The present studies were undertaken to compare anemia-induced erythropoietic responses in femoral marrows and spleens of mice pretreated with Adriamycin (ADR) or 1-β-D-arabinofuranosylcytosine with those of untreated age-matched controls. Mice were bled 45 or 120 days after drug treatment. The erythropoietic response to bleeding was quantitated by morphological, gravimetric, and radioiron methods 48 hr after bleeding. At 120 days after ADR, prebleeding base-line cellularity parameters were, in general, similar to those found in untreated age-matched controls. The response to the anemia stress was compared in drug-treated animals and in age-matched untreated controls, and the response deficit was expressed as residual injury (RI). At 120 days, ADR-induced RI was observed to be dose dependent in both femoral marrow and spleen. ADR-induced RI in femoral marrow and spleen were similar at 45 and 120 days, with no significant recovery. Although marrow RI was noted 45 days after 200 mg 1-β-D-arabinofuranosylcytosine per kg, there was no RI at 120 days. The results indicate that ADR can induce a long-lasting hematopoietic injury which is not obvious from measures of homeostatic cellularity, but which can be expressed after induction of an acute proliferative demand.

Original languageEnglish
Pages (from-to)2257-2262
Number of pages6
JournalCancer Research
Volume40
Issue number7
StatePublished - Jan 1 1980
Externally publishedYes

Fingerprint

Doxorubicin
Anemia
Wounds and Injuries
Thigh
Bone Marrow
Spleen
Cytarabine
Hemorrhage
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Braunschweiger, P. G., Schenken, L. L., & Schiffer, L. M. (1980). Adriamycin-induced delayed erythropoietic injury expressed following anemia stress. Cancer Research, 40(7), 2257-2262.

Adriamycin-induced delayed erythropoietic injury expressed following anemia stress. / Braunschweiger, Paul G; Schenken, L. L.; Schiffer, L. M.

In: Cancer Research, Vol. 40, No. 7, 01.01.1980, p. 2257-2262.

Research output: Contribution to journalArticle

Braunschweiger, PG, Schenken, LL & Schiffer, LM 1980, 'Adriamycin-induced delayed erythropoietic injury expressed following anemia stress', Cancer Research, vol. 40, no. 7, pp. 2257-2262.
Braunschweiger PG, Schenken LL, Schiffer LM. Adriamycin-induced delayed erythropoietic injury expressed following anemia stress. Cancer Research. 1980 Jan 1;40(7):2257-2262.
Braunschweiger, Paul G ; Schenken, L. L. ; Schiffer, L. M. / Adriamycin-induced delayed erythropoietic injury expressed following anemia stress. In: Cancer Research. 1980 ; Vol. 40, No. 7. pp. 2257-2262.
@article{865e33d620a748b58627eb5170dd2f59,
title = "Adriamycin-induced delayed erythropoietic injury expressed following anemia stress",
abstract = "The present studies were undertaken to compare anemia-induced erythropoietic responses in femoral marrows and spleens of mice pretreated with Adriamycin (ADR) or 1-β-D-arabinofuranosylcytosine with those of untreated age-matched controls. Mice were bled 45 or 120 days after drug treatment. The erythropoietic response to bleeding was quantitated by morphological, gravimetric, and radioiron methods 48 hr after bleeding. At 120 days after ADR, prebleeding base-line cellularity parameters were, in general, similar to those found in untreated age-matched controls. The response to the anemia stress was compared in drug-treated animals and in age-matched untreated controls, and the response deficit was expressed as residual injury (RI). At 120 days, ADR-induced RI was observed to be dose dependent in both femoral marrow and spleen. ADR-induced RI in femoral marrow and spleen were similar at 45 and 120 days, with no significant recovery. Although marrow RI was noted 45 days after 200 mg 1-β-D-arabinofuranosylcytosine per kg, there was no RI at 120 days. The results indicate that ADR can induce a long-lasting hematopoietic injury which is not obvious from measures of homeostatic cellularity, but which can be expressed after induction of an acute proliferative demand.",
author = "Braunschweiger, {Paul G} and Schenken, {L. L.} and Schiffer, {L. M.}",
year = "1980",
month = "1",
day = "1",
language = "English",
volume = "40",
pages = "2257--2262",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - Adriamycin-induced delayed erythropoietic injury expressed following anemia stress

AU - Braunschweiger, Paul G

AU - Schenken, L. L.

AU - Schiffer, L. M.

PY - 1980/1/1

Y1 - 1980/1/1

N2 - The present studies were undertaken to compare anemia-induced erythropoietic responses in femoral marrows and spleens of mice pretreated with Adriamycin (ADR) or 1-β-D-arabinofuranosylcytosine with those of untreated age-matched controls. Mice were bled 45 or 120 days after drug treatment. The erythropoietic response to bleeding was quantitated by morphological, gravimetric, and radioiron methods 48 hr after bleeding. At 120 days after ADR, prebleeding base-line cellularity parameters were, in general, similar to those found in untreated age-matched controls. The response to the anemia stress was compared in drug-treated animals and in age-matched untreated controls, and the response deficit was expressed as residual injury (RI). At 120 days, ADR-induced RI was observed to be dose dependent in both femoral marrow and spleen. ADR-induced RI in femoral marrow and spleen were similar at 45 and 120 days, with no significant recovery. Although marrow RI was noted 45 days after 200 mg 1-β-D-arabinofuranosylcytosine per kg, there was no RI at 120 days. The results indicate that ADR can induce a long-lasting hematopoietic injury which is not obvious from measures of homeostatic cellularity, but which can be expressed after induction of an acute proliferative demand.

AB - The present studies were undertaken to compare anemia-induced erythropoietic responses in femoral marrows and spleens of mice pretreated with Adriamycin (ADR) or 1-β-D-arabinofuranosylcytosine with those of untreated age-matched controls. Mice were bled 45 or 120 days after drug treatment. The erythropoietic response to bleeding was quantitated by morphological, gravimetric, and radioiron methods 48 hr after bleeding. At 120 days after ADR, prebleeding base-line cellularity parameters were, in general, similar to those found in untreated age-matched controls. The response to the anemia stress was compared in drug-treated animals and in age-matched untreated controls, and the response deficit was expressed as residual injury (RI). At 120 days, ADR-induced RI was observed to be dose dependent in both femoral marrow and spleen. ADR-induced RI in femoral marrow and spleen were similar at 45 and 120 days, with no significant recovery. Although marrow RI was noted 45 days after 200 mg 1-β-D-arabinofuranosylcytosine per kg, there was no RI at 120 days. The results indicate that ADR can induce a long-lasting hematopoietic injury which is not obvious from measures of homeostatic cellularity, but which can be expressed after induction of an acute proliferative demand.

UR - http://www.scopus.com/inward/record.url?scp=0018855934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018855934&partnerID=8YFLogxK

M3 - Article

C2 - 7388791

AN - SCOPUS:0018855934

VL - 40

SP - 2257

EP - 2262

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 7

ER -